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Abstract:  A subchronic feeding study of L-serine (L-Ser) was conducted with groups of 10 male and 10 female Fischer
344 rats fed a powder diet containing 0, 0.06, 0.5, 1.5 or 5.0% concentrations of L-Ser for 90 days.  There were no
toxicologically significant, treatment-related changes with regards to body weight, food intake, water intake or urinalysis
data.  In several of the hematology, serum biochemistry and organ weight parameters, significant changes were observed
between some of the treated groups and the controls.  All these changes, however, were subtle and lacked any
corresponding pathological findings.  In addition, the increased or decreased values remained within the range of the
historical control values.  In fact, histopathological assessment revealed only sporadic and/or spontaneous lesions.  In
conclusion, the no-observed-adverse-effect-level (NOAEL) for L-Ser was, therefore, determined to be at least a dietary
dose of 5.0% (2765.0 mg/kg body weight/day for males and 2905.1 mg/kg body weight/day for females) under the
present experimental conditions.   (J Toxicol Pathol 2010; 23: 39–47)
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Introduction
L-Serine ((S)-2-amino-3-hydroxypropanoic acid; L-
Ser) [CAS No.56-45-1] is a nutritionally non-essential
amino acid that is synthesized from D-3-phosphoglycerate,
an intermediate in the glycolytic pathway, or from glycine
via the freely reversible serine hydroxymethyltransferase
reaction.  L-Ser is approved in Japan as an existing food
additive for seasoning of the diet1 and has recently become
widely used as an ingredient of supplements, health foods
and cosmetics.  In addition, L-Ser and its metabolic
byproducts have been recognized to be not only essential for
cell proliferation, but also necessary for specific functions in
the central nervous system2,3.  Under these circumstances,
potential risks of L-Ser must be well assessed and
appropriately managed.  There are, however, few reports
available regarding the toxicity of L-Ser.
The oral 50% lethal dose (LD50) of L-Ser for rats has
been determined to be 14 (12.8–15.3) g/kg body weight4.  In
the reviews of Harper et al. in regard to the effects of
disproportionate intake levels of amino acids5 and of Garlick
in regard to the safety of individual amino acids taken in
excess relative to the amounts absorbed from dietary
protein6, excessive dietary levels of L-Ser have clearly been
shown to depress the growth of rats fed low-protein diets.  D-
serine and DL-serine administered by several routes have
been shown to affect growth and to produce renal necrosis5,7.
On the other hand, L-Ser has been shown to induce
significant increase of sister-chromatid exchanges in
peripheral blood lymphocytes8.  The information available
concerning the potential risks of L-Ser is thus limited, and
considering the human exposure situation, the risks need to
be assessed in an urgent but careful manner by well-
established protocols.
As previously described in our reports concerning
safety assessment for L-aspartic acid9, the Ministry of
Health, Labour and Welfare (MHLW) of Japan is
responsible for risk assessment and management of food
additives in collaboration with the Food Safety Commission
of Japan.  In response to this issue, the MHLW has been
funding research through grants, and the present 90-day
feeding toxicity study of L-Ser in Fischer 344 rats was
conducted as a part of this effort.  It is important to note that
the present study was conducted utilizing a purified 20%
casein diet in order to exclude possible influence and
interference due to the presence of other amino acids.
Received: 30 September 2009, Accepted: 24 November 2009
Mailing address: Yukie Tada, Department of Environmental Health 
and Toxicology, Tokyo Metropolitan Institute of Public Health, 3–24–
1, Hyakunin’cho, Shin’juku, Tokyo 169-0073, Japan
TEL: 81-3-3363-3231  FAX: 81-3-3368-4060
E-mail: Yukie_Tada@member.metro.tokyo.jp40 A 90-day Feeding Toxicity Study of L-Ser
Materials and Methods
Ethical considerations
The current study was performed in accordance with
the “Guidelines for Designation of Food Additives and for
Revision of Standards for Use of Food Additives” released
by the MHLW (Eika No. 29, March 22nd, 1996).  The
experimental protocol was approved prior to its execution by
our in-house committee, which monitored every step during
the experimentation for its scientific and ethical propriety,
with strict obedience to the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals,
Japanese Government Animal Protection and Management
Law, Japanese Government Notification on Feeding and
Safekeeping of Animals and Guidelines for Animal
Experimentation (released by the Japanese Association for
Laboratory Animal Science)10.
Test chemical and diet preparation
L-Ser (lot number, 0000033701; purity, 100.3%,
assessed by a neutralizing titration method) was generously
supplied by Ajinomoto Co., Inc.  (Kanagawa, Japan).  It was
admixed into a modified AIN-93G powder diet (Oriental
Yeast Co., Ltd., Tokyo, Japan) to produce concentrations of
0 (control), 0.06, 0.5, 1.5 or 5.0% every 4 weeks; the diet
composition is shown in Table 1.  It should be noted here that
the 0.06% group was used to assess the effects of a human-
relevant dose (Worldsuppli.jp2) and thus should be
considered as an additional group to a standard 3-dose safety
assessment study protocol.  The 0.06% dose is thus 8.3-fold
lower than the immediate upper dose of 0.5%, while the
other doses were set with the common ratios of 3.0–3.3.  The
L-Ser content in all experimental diets was analyzed at their
preparation, and the actual values were 0.64 ± 0.02, 4.88 ±
0.22, 15.06 ± 0.06 and 54.08 ± 1.97 g/kg diet for the 0.06,
0.5, 1.5 and 5.0% doses, respectively.  After keeping the 0.06
and 5.0% diets for 7 days at 22–24°C or for 30 days at 4°C,
the contents of L-Ser were found to remain fairly stable, with
values of 0.66 and 54.37 g/kg diet or 0.66 and 54.73 g/kg
diet, respectively.
Animals and treatments
A total of 55 male and 55 female specific pathogen-free
Fischer 344 (F344/DuCrlCrlj) rats were purchased at 5
weeks of age from Charles River Japan Inc.  (Kanagawa,
Japan) and acclimatized to the control diet for 1 week before
the start of the experiment.  The rats were housed
individually in stainless steel cages; kept under the
controlled conditions of temperature (23 ± 2°C), relative
humidity (55 ± 10%) and ventilation (more than 10 times/
hour) with a 12-hour light/dark cycle; and allowed free
access to food and drinking water throughout both the
acclimation and experimentation periods.  After confirming
normal health status at the end of the acclimation period, 50
rats of each sex were selected for use (5 rats of each sex
being omitted), randomly allocated to 5 groups each
consisting of 10 rats and given the control or experimental
diets for 90 days.  During the experimentation period, the
rats were observed daily, and clinical signs and mortality (if
any) were recorded.  Body weight and food and water
intakes were monitored weekly.
Animal sacrifice and assessments
At the end of the experimentation period of 90 days, all
rats were deprived of food (but not water) overnight, and
fresh urine samples were obtained for urinalysis of
urobilinogen, occult blood, bilirubin, ketone, glucose,
protein, pH and nitrous acid using reagent strips (N-
Multistix, Siemens Medical Solutions Diagnostics Ltd.,
Tokyo, Japan).  All rats were then lightly anesthetized and
sacrificed by exsanguination after collecting blood samples
via the abdominal aorta.  Using the blood samples and
subsequently prepared sera, hematological and serological
examinations were performed.  Hematological examination
was carried out using an automatic analyzer (Sysmex KX-
21NV; Sysmex Co., Hyogo, Japan) for the red blood cell
count (RBC), hemoglobin concentration (HGB), hematocrit
level (HCT), mean corpuscular volume (MCV), mean
corpuscular hemoglobin (MCH), mean corpuscular
hemoglobin concentration (MCHC), white blood cell count
(WBC) and platelet count (PLT).  Differential counts of
leukocytes were made by a light microscopic observation of
smeared specimens stained with a routine May-Grünwald-
Giemsa protocol.  Serum biochemistry determination was
performed with another automatic analyzer (TBA-120FR;
Toshiba Medical Systems Co., Tokyo, Japan) for the levels
of total protein (TP), albumin (ALB), albumin/globulin ratio
(A/G), glucose (GLU), total cholesterol (T-CHO),
triglyceride (TG), total bilirubin (T-BIL), blood urea
nitrogen (BUN), creatinine (CRE), uric acid (UA), aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
alkaline phosphatase (ALP), sodium (Na), potassium (K),
chlorine (Cl) and calcium (Ca).  At terminal sacrifice,
complete necropsies were performed on all animals.  For
each animal, the body weight was determined, and gross
observations were made.  The brain, thyroids (with
parathyroids), heart, spleen, liver, adrenals, kidneys, testes,
ovaries and uterus were then excised, and their absolute and
Table 1. Composition of a Modified AIN-93G Diet Containing L-Ser
Ingredient (g/kg dry matter)
β-Cornstarch 629.486–X
Casein (vitamin free) 200.000
Soybean oil (no additives) 70.000
Cellulose powder 50.000
Mineral mix (AIN-93G) 35.000
Vitamin mix (AIN-93G) 10.000
L-Cystine 3.000
Choline bitartrate (41.1% choline) 2.500
tert-Butylhydroquinone 0.014
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relative weights were determined.  These organs as well as
the pituitary gland, eyes, harderian glands, thymus, nasal
cavity, trachea, lungs (including bronchi, fixed by inflation
with fixative), salivary glands, tongue, esophagus, stomach,
duodenum, jejunum, ileum, caecum, rectum, pancreas,
urinary bladder, skin with mammary gland, skeletal muscle,
epididymides, seminal vesicles, prostate, preputials,
oviducts, vagina, lymph nodes (submandibular and
mesenteric), thoracic aorta, sciatic nerve, spinal cords
(cervical, mid-thoracic and lumbar), bones (femur and
sternum) with bone marrows, Zymbal’s glands and all gross
lesions of each animal were fixed in 10% neutrally buffered
formalin.  Paraffin-embedded sections were then routinely
prepared.  All organs of the control and all treated groups
were histopathologically examined by using these sections
stained via a routine hematoxylin and eosin (HE) protocol.
Statistical analysis
For numerical data such as body and organ weights as
well as hematological and serological outcomes, equality of
means between the control and each treated group values
was assessed by Bartlett’s test.  Homogeneity of variance
was then analyzed by a one-way analysis of variance, and
differences between the control and treated group values
were evaluated by Dunnett’s test.  On the other hand, if the
Bartlett’s test was significant, the data were subjected to the
Kruskal-Wallis test and the Dunnett’s type rank sum test.
For contingent data such as incidences of histopathological
lesions and positive cases of urinalysis, differences between
the control and treated group values were evaluated by the
Fisher’s exact probability test11.  Statistical processing was
conducted using a StatLight software (Yukms Ltd., Tokyo,
Japan).  Intergroup differences were considered statistically
significant when p-values less than 0.05 were obtained.
Results
General findings
No rats died or became moribund until the end of the
experiment.  No treatment-related clinical signs were
observed in the control or treated rats during the study.
There were no significant differences in average body
weights (Fig. 1) or average daily food and water intakes
(Table 2) between the rats in the control group and those in
any of the treated groups during the study (for both sexes).
The average L-Ser intake of each group was calculated as
demonstrated in Table 2.
Fig. 1. Weekly changes in the average body weights of Fischer 344
rats (10 animals for each group) given L-serine at dietary doses
of 0 (control, open circles), 0.06 (closed triangles), 0.5 (closed
circles), 1.5 (asterisks) or 5.0% (closed squares) for 90 days.
Table 2. Average Daily Food, Water and Chemical Intakes in Fischer 344 Rats Given L-Ser for 90 Days
Item Dietary dose of L-Ser (%)
0 (control) 0.06 0.5 1.5 5.0
Male
Effective number of rats 10 10 10 10 10
Food intake (g/kg body weight/day) 55.3 ± 17.0a 55.2 ± 17.3 54.9 ± 16.8 55.2 ± 16.1 55.3 ± 15.7
Water intake (mL/kg body weight/day) 59.5 ± 17.4 59.4 ± 16.8 59.5 ± 16.7 63.4 ± 17.3 61.7 ± 16.1
Chemical intake (mg/kg body weight/day) – 33.1 ± 10.4 274.7 ± 83.9 827.6 ± 241.7 2765.0 ± 785.3
Female
Effective number of rats 10 10 10 10 10
Food intake (g/kg body weight/day) 59.4 ± 14.4 58.7 ± 13.5 58.5 ± 13.5 59.5 ± 13.1 58.1 ± 12.2
Water intake (mL/kg body weight/day) 80.1 ± 18.7 80.2 ± 18.8 80.2 ± 17.2 78.6 ± 18.0 74.9 ± 15.4
Chemical intake (mg/kg body weight/day) – 35.2 ± 8.1 292.5 ± 67.5 892.6 ± 196.9 2905.1 ± 612.2
aValues are means ± standard deviations.42 A 90-day Feeding Toxicity Study of L-Ser
Urinalysis
Comparison of the results of urinalysis between the
treatment and control groups revealed no treatment-related
changes in the analyzed parameters.
Hematology and serum biochemistry
In the male rats, the MCV and MCH values of the 5.0%
groups and MCHC values of the 0.06, 1.5 and 5.0% groups
were significantly lower than those of the control group
(Table 3).  In the female rats, the RBC and PLT of the 5.0%
group were significantly higher than those of the control
group, while the MCV of the 5.0% group, MCH of the 1.5
and 5.0% group, MCHC of the 0.5% or greater groups were
significantly lowered.  However, all of these changes were
subtle.  The morphological findings and differential counts
of leukocytes showed no significant adverse effects in any of
the treated groups.
Serum biochemistry demonstrated that the values for
TP of the 5.0% males and females, ALB of the 5.0% males,
UA of the 1.5% or greater males, AST of the 5.0% males and
females, and K of the 0.5% or greater males were
significantly, although slightly, lower than those of the
controls (Table 4).  GGT of the 5.0% females, Na of the
1.5% males and 0.5% or greater females and Cl of the 0.5%
or greater females were significantly, although slightly,
higher than those of the controls (Table 4).
Organ weights
There were no significant differences in final body
weights between the rats in the control and treated groups
(for both sexes).  In the male rats, the relative testes weight
of the 0.06% group and relative kidney weight of the 5.0%
group were significantly, although slightly, higher than those
of the controls (Table 5).  In the female rats, the relative
weights of the brain, spleen, liver and kidneys of the 5.0%
group were significantly, although subtly, higher than those
Table 3. Hematology in Fischer 344 Rats Given L-Ser for 90 Days
Item Dietary dose of L-Ser (%)
0 (control) 0.06 0.5 1.5 5.0
Males
Effective number of rats 10a 10 10 10 10
RBC (× 104/μL) 903.9 ± 26.1b 910.7 ± 16.6 894.4 ± 15.5 896.6 ± 14.8 916.5 ± 16.0
HGB (g/dL) 15.1 ± 0.4 15.1 ± 0.3 14.9 ± 0.2 14.9 ± 0.1 15.0 ± 0.3
HCT (%) 47.4 ± 1.3 48.1 ± 1.1 47.1 ± 0.7 47.2 ± 0.7 47.6 ± 1.0
MCV (fL) 52.4 ± 0.3 52.8 ± 0.5 52.7 ± 0.2 52.6 ± 0.4 51.9 ± 0.3*
MCH (pg) 16.7 ± 0.2 16.6 ± 0.1 16.7 ± 0.1 16.6 ± 0.2 16.3 ± 0.2*
MCHC (g/dL) 31.8 ± 0.3 31.5 ± 0.2* 31.7 ± 0.2 31.6 ± 0.3* 31.4 ± 0.2*
WBC (× 102/μL) 44.0 ± 10.0 46.0 ± 7.6 39.6 ± 9.7 44.7 ± 17.4 46.9 ± 16.4
  Lymphocyte (× 102/μL) 30.3 ± 7.6 31.7 ± 7.1 27.4 ± 9.1 29.6 ± 12.9 28.5 ± 9.4
  Neutrophil (× 102/μL) 12.8 ± 3.6 13.3 ± 3.1 11.3 ± 2.2 14.2 ± 5.8 17.2 ± 7.5
  Eosinophil (× 102/μL) 0.3 ± 0.3 0.3 ± 0.3 0.6 ± 0.6 0.4 ± 0.3 0.6 ± 0.5
  Basophil (× 102/μL) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
  Monocyte (× 102/μL) 0.6 ± 0.4 0.7 ± 0.5 0.3 ± 0.4 0.6 ± 0.3 0.7 ± 0.4
  Others (× 102/μL) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
PLT (× 104/μL) 60.9 ± 4.0 60.9 ± 3.8 59.3 ± 1.9 59.4 ± 2.9 54.1 ± 10.5
Females
Effective number of rats 9 10 10 10 8
RBC (× 104/μL) 883.3 ± 14.4 876.9 ± 22.2 879.8 ± 14.2 877.8 ± 27.0 921.6 ± 13.0*
HGB (g/dL) 15.7 ± 0.2 15.5 ± 0.4 15.6 ± 0.2 15.4 ± 0.4 15.7 ± 0.4
HCT (%) 47.9 ± 0.9 47.7 ± 1.2 48.0 ± 0.7 47.6 ± 1.4 49.1 ± 0.9
MCV (fL) 54.3 ± 0.3 54.4 ± 0.3 54.5 ± 0.3 54.2 ± 0.3 53.3 ± 0.4*
MCH (pg) 17.8 ± 0.1 17.7 ± 0.1 17.7 ± 0.2 17.6 ± 0.2* 17.1 ± 0.2*
MCHC (g/dL) 32.8 ± 0.3 32.5 ± 0.3 32.4 ± 0.3* 32.4 ± 0.3* 32.0 ± 0.2*
WBC (× 102/μL) 31.1 ± 5.9 31.1 ± 7.1 28.6 ± 6.5 33.7 ± 9.4 35.1 ± 6.7
  Lymphocyte × 102/μL) 25.2 ± 4.7 23.3 ± 7.8 20.6 ± 5.7 25.6 ± 7.8 27.5 ± 7.1
  Neutrophil (× 102/μL) 5.3 ± 1.8 7.2 ± 3.1 7.4 ± 2.1 7.7 ± 2.7 7.1 ± 3.1
  Eosinophil (× 102/μL) 0.3 ± 0.1 0.2 ± 0.3 0.3 ± 0.4 0.4 ± 0.3 0.3 ± 0.3
  Basophil (× 102/μL) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
  Monocyte (× 102/μL) 0.3 ± 0.3 0.3 ± 0.3 0.3 ± 0.2 0.3 ± 0.3 0.2 ± 0.2
  Others (× 102/μL) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
PLT (× 104/μL) 53.8 ± 14.5 61.2 ± 5.5 61.9 ± 4.7 59.4 ± 13.1 66.9 ± 3.6* 
a Effective numbers smaller than 10 occurred due to failure in collection of samples.  b Values are means ± standard deviations.  *Significantly
different from the corresponding control values (p<0.05, Dunnett’s test).Tada, Yano, Takahashi et al. 43
of the controls (Table 5).
Pathology
No treatment-related macroscopic changes were
observed in any organs of either sex.  In the
histopathological study, there were no treatment-related
changes in any organs (for both sexes), whereas only
sporadic spontaneous lesions were observed similarly in the
control and treated animals.  Spontaneous lesions in the liver
and kidney are shown in Table 6.
Discussion
In the present 90-day feeding toxicity study of L-Ser in
Fischer 344 rats, no treatment-related deaths, body weight
changes, food and water intake changes or clinical signs
were observed in either sex.  In the literature, only a few
inconsistent data are available with this regard.  According to
Muramatsu et al., L-Ser at a dietary dose of 5.0% depressed
the growth of Donryu rats during an experimentation period
of 3 weeks, and the body weight gain was 34 ± 5 g and 69 ±
5 g for the L-Ser-treated and control animals, respectively12.
Moreover, L-Ser at the levels of 2.1, 4.2 or 6.3% in diets
Table 4. Serum Biochemistry in Fischer 344 Rats Given L-Ser for 90 Days
Item Dietary dose of L-Ser (%)
0 (control) 0.06 0.5 1.5 5.0
Male
Effective number of rats 10 10 10 10 10
TP (g/dL) 6.89 ± 0.19a 6.86 ± 0.13 6.81 ± 0.11 6.76 ± 0.19 6.62 ± 0.18*
ALB (g/dL) 4.46 ± 0.09 4.43 ± 0.06 4.41 ± 0.07 4.41 ± 0.10 4.33 ± 0.08*
A/G 1.84 ± 0.09 1.83 ± 0.08 1.84 ± 0.08 1.88 ± 0.08 1.90 ± 0.11
GLU (mg/dL) 134.6 ± 9.8 126.7 ± 8.7 135.0 ± 11.3 129.7 ± 11.1 138.2 ± 14.1
T-CHO (mg/dL) 70.7 ± 7.4 66.5 ± 8.0 70.4 ± 9.5 68.5 ± 7.3 65.8 ± 5.8
TG (mg/dL) 91.9 ± 27.6 78.9 ± 24.7 91.0 ± 43.5 76.3 ± 31.3 76.2 ± 27.4
T-BIL (mg/dL) 0.01 ± 0.00 0.01 ± 0.01 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
BUN (mg/dL) 14.6 ± 1.5 14.8 ± 1.4 14.5 ± 1.5 14.8 ± 1.9 14.6 ± 1.1
CRE (mg/dL) 0.27 ± 0.02 0.27 ± 0.02 0.27 ± 0.02 0.28 ± 0.01 0.27 ± 0.02
UA (mg/dL) 1.34 ± 0.20 1.26 ± 0.22 1.16 ± 0.17 1.13 ± 0.18* 1.07 ± 0.12*
AST (U/L) 91.2 ± 17.9 87.2 ± 9.2 87.1 ± 10.4 84.3 ± 8.8 74.0 ± 7.9*
ALT (U/L) 44.1 ± 4.6 41.6 ± 5.6 43.1 ± 6.6 43.8 ± 4.5 38.8 ± 6.7
GGT (U/L) 0.00 ± 0.00 0.30 ± 0.48 0.10 ± 0.32 0.20 ± 0.42 0.10 ± 0.32
ALP (U/L) 361.2 ± 26.3 364.2 ± 23.7 370.5 ± 22.7 356.8 ± 23.4 355.1 ± 27.9
Na (mmol/L) 158.5 ± 0.2 158.6 ± 0.1 158.6 ± 0.1 158.7 ± 0.2* 158.7 ± 0.1
K (mmol/L) 7.00 ± 0.13 6.89 ± 0.07 6.76 ± 0.10* 6.77 ± 0.10* 6.70 ± 0.11*
Cl (mmol/L) 117.8 ± 0.3 117.9 ± 0.2 117.9 ± 0.2 117.9 ± 0.3 117.9 ± 0.1
Ca (mg/dL) 10.8 ± 0.2 10.7 ± 0.1 10.7 ± 0.1 10.7 ± 0.2 10.7 ± 0.2
Female
Effective number of rats 10 10 10 10 10
TP (g/dL) 6.68 ± 0.19 6.59 ± 0.16 6.64 ± 0.17 6.49 ± 0.23 6.43 ± 0.21*
ALB (g/dL) 4.40 ± 0.11 4.36 ± 0.09 4.38 ± 0.07 4.30 ± 0.13 4.28 ± 0.14
A/G 1.93 ± 0.08 1.95 ± 0.09 1.94 ± 0.12 1.96 ± 0.07 2.00 ± 0.08
GLU (mg/dL) 111.2 ± 26.9 106.8 ± 16.5 106.7 ± 11.8 99.1 ± 13.2 94.8 ± 6.6
T-CHO (mg/dL) 68.3 ± 6.0 66.9 ± 6.9 66.3 ± 6.9 64.2 ± 6.7 65.9 ± 4.2
TG (mg/dL) 17.3 ± 6.3 15.9 ± 6.7 14.0 ± 4.3 13.0 ± 3.5 13.4 ± 2.1
T-BIL (mg/dL) 0.01 ± 0.01 0.01 ± 0.01 0.01 ± 0.01 0.02 ± 0.01 0.01 ± 0.01
BUN (mg/dL) 16.7 ± 1.4 17.7 ± 1.2 16.9 ± 2.6 16.7 ± 1.5 16.2 ± 2.1
CRE (mg/dL) 0.31 ± 0.04 0.31 ± 0.03 0.30 ± 0.01 0.30 ± 0.03 0.29 ± 0.01
UA (mg/dL) 1.36 ± 0.22 1.41 ± 0.20 1.38 ± 0.27 1.20 ± 0.16 1.19 ± 0.16
AST (U/L) 84.7 ± 10.7 101.2 ± 37.6 101.2 ± 46.2 113.3 ± 72.1 71.5 ± 4.9*
ALT (U/L) 32.2 ± 2.8 34.4 ± 6.4 31.9 ± 6.6 34.6 ± 11.1 30.6 ± 3.8
GGT (U/L) 0.20 ± 0.42 0.50 ± 0.53 0.40 ± 0.52 0.40 ± 0.52 0.88 ± 0.35*
ALP (U/L) 277.9 ± 35.5 279.8 ± 12.7 290.4 ± 32.9 289.7 ± 22.2 274.4 ± 18.6
Na (mmol/L) 158.6 ± 0.1 158.6 ± 0.1 158.8 ± 0.1* 158.8 ± 0.1* 158.9 ± 0.1*
K (mmol/L) 6.89 ± 0.10 6.80 ± 0.19 6.76 ± 0.21 6.71 ± 0.18 6.76 ± 0.14
Cl (mmol/L) 118.3 ± 0.2 118.4 ± 0.2 118.6 ± 0.2* 118.5 ± 0.3* 118.6 ± 0.2*
Ca (mg/dL) 10.4 ± 0.2 10.3 ± 0.2 10.4 ± 0.3 10.5 ± 0.4 10.4 ± 0.3
a Values are means ± standard deviations.  *Significantly different from the corresponding control values (p<0.05, Dunnett’s test).44 A 90-day Feeding Toxicity Study of L-Ser
resulted in growth reductions of 6, 25 and 29%,
respectively13.
In the L-Ser-administered groups, statistically
significant changes were detected in some hematological
parameters, such as RBC (high in the 5% females), MCV,
MCH and MCHC (low in the 1.5 or 5% rats of both sexes).
However, these hematological changes were slight and
lacked dose-dependence within the range of the historic
control values14.  Furthermore, no abnormalities were
observed in the microscopically assessed red blood cell
figures in blood smears or on histopathological examination
of hematopoietic organs.  The observed hematological
Table 5. Absolute and Relative Organ Weights in Fischer 344 Rats Given L-Ser for 90 Days
Item Dietary dose of L-Ser (%)
0 (control) 0.06 0.15 1.5 5.0
Male
Effective number of rats 10 10 10 10 10
Final body weight (g) 308.1 ±17.2b 294.0 ± 9.7 306.3 ± 14.8 313.4 ± 9.2 303.7 ± 15.8
Absolute organ weight (mg)
Brain 2029.3 ± 34.6 2008.3 ± 44.0 2003.9 ± 14.0 2020.2 ± 24.5 1995.3 ± 19.8
Thyroidsa 15.1 ± 2.4 12.7 ± 1.8* 14.9 ± 0.8 14.6 ± 1.6 15.2 ± 1.0
Heart 835.7 ± 35.4 835.5 ± 37.4 850.3 ± 55.8 855.1 ± 43.6 845.4 ± 59.5
Spleen 620.5 ± 64.2 588.5 ± 36.4 603.9 ± 39.8 618.6 ± 21.3 603.1 ± 33.4
Liver 6954.4 ± 525.3 6562.5 ± 353.5 6930.0 ± 608.6 6919.2 ± 467.1 6780.3 ± 560.2
Adrenals 39.52 ± 3.8 39.3 ± 2.2 37.6 ± 2.7 38.7 ± 2.7 38.1 ± 3.6
Kidneys 1752.9 ± 90.8 1705.6 ± 76.8 1739.5 ± 66.4 1792.6 ± 39.5 1782.3 ± 74.9
Testes 3061.7 ± 115.6 3130.7 ± 111.9 3044.9 ± 89.2 3111.9 ± 82.1 3037.7 ± 118.7
Relative organ weight (mg/100 g body weight)
Brain 660.1 ± 30.2 683.5 ± 19.4 655.6 ± 32.1 645.2 ± 22.2 658.4 ± 32.7
Thyroids 4.92 ± 0.75 4.31 ± 0.63 4.88 ± 0.38 4.64 ± 0.43 5.01 ± 0.24
Heart 271.6 ± 10.1 284.3 ± 11.2 277.7 ± 15.2 272.9 ± 11.2 278.2 ± 10.5
Spleen 201.1 ± 11.9 200.1 ± 9.8 197.1 ± 7.4 197.5 ± 5.7 198.5 ± 3.2
Liver 2255.6 ± 67.6 2231.0 ± 60.1 2259.0 ± 102.6 2207.2 ± 113.4 2230.2 ± 96.7
Adrenals 12.9 ± 1.4 13.4 ± 0.8 12.3 ± 1.1 12.3 ± 0.8 12.5 ± 1.0
Kidneys 569.2 ± 15.4 580.0 ± 15.9 568.3 ± 12.2 572.2 ± 8.3 587.4 ± 23.5*
Testes 995.2 ± 40.8 1065.0 ± 27.0* 995.1 ± 25.3 993.4 ± 22.6 1001.7 ± 48.5
Female
Effective number of rats 10 10 10 10 10
Final body weight (g) 163.5 ± 9.6 159.6 ± 9.9 163.1 ± 7.8 163.7 ± 7.6 154.3 ± 8.6
Absolute organ weight (mg)
Brain 1821.1 ± 36.9 1851.4 ± 29.9 1852.6 ± 30.4 1853.8 ± 18.7 1845.6 ± 43.9
Thyroids 11.1 ± 1.3 11.0 ± 1.1 10.3 ± 1.3 13.1 ± 2.3* 10.8 ± 1.5
Heart 519.4 ± 26.1 517.6 ± 33.3 509.8 ± 28.4 519.1 ± 21.0 513.0 ± 28.9
Spleen 355.4 ± 12.0 360.5 ± 26.3 356.5 ± 23.4 377.1 ± 29.8 377.1 ± 29.8
Liver 3421.2 ± 221.5 3331.3 ± 237.1 3419.7 ± 185.7 3395.0 ± 226.1 3442.1 ± 204.1
Adrenals 42.3 ± 3.5 41.8 ± 3.4 42.9 ± 3.0 42.4 ± 1.8 42.3 ± 2.3
Kidneys 970.6 ± 38.5 966.2 ± 50.1 991.4 ± 38.5 1006.7 ± 44.7 1015.4 ± 59.9
Ovaries 48.2 ± 5.5 45.8 ± 4.8 47.2 ± 2.6 51.2 ± 6.5 46.5 ± 12.9
Uterus 382.8 ± 62.8 380.5 ± 72.2 415.5 ± 39.4 377.9 ± 77.4 342.1 ± 46.5
Relative organ weight (mg/100 g body weight)
Brain 1117.5 ± 67.0 1163.9 ± 64.6 1138.2 ± 52.2 1134.4 ± 51.3 1192.4 ± 71.2*
Thyroids 6.85 ± 1.18 6.87 ± 0.64 6.30 ± 0.73 8.03 ± 1.49 6.91 ± 1.03
Heart 318.3 ± 16.6 324.7 ± 15.3 312.8 ± 16.0 317.3 ± 11.3 329.6 ± 8.2
Spleen 217.9 ± 12.4 226.0 ± 11.0 218.8 ± 13.5 230.2 ± 12.7 232.1 ± 9.7*
Liver 2094.3 ± 94.4 2090.5 ± 133.8 2097.5 ± 73.5 2072.2 ± 61.8 2221.4 ± 104.0*
Adrenals 26.0 ± 2.8 26.2 ± 2.3 26.3 ± 2.0 25.9 ± 1.4 27.4 ± 1.5
Kidneys 595.4 ± 39.4 606.6 ± 31.8 608.8 ± 27.3 615.2 ± 16.5 652.8 ± 32.8*
Ovaries 29.5 ± 3.0 28.7 ± 2.8 29.0 ± 2.3 31.3 ± 3.5 29.8 ± 8.1
Uterus 235.2 ± 42.8 238.7 ± 42.4 255.2 ± 26.5 230.6 ± 44.2 222.7 ± 27.1
a Thyroids were weighed after fixation.  b Values are means ± standard deviations.  *Significantly different from the corresponding control
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changes can therefore be considered incidental and not
treatment-related.
The serum TP (in the 5.0% males and females) and
ALB (in 5.0% males) levels were significantly lower than
those of the control groups.  Although these decreases
showed dose-dependent tendencies, all changes were
marginal, and the values in the L-Ser-administered groups
were within the range of the historical control values15.
Moreover, no corresponding pathological findings were
observed.  It is thus conceivable that the changes were
toxicologically insignificant, even if they were treatment-
related.  Serine dehydratase (SDH) is induced by feeding of
a synthetic diet containing L-Ser as a sole source of non-
essential amino nitrogen (Serine diet).  Of the non-essential
amino acids tested, only L-Ser causes SDH induction, and
the extent of such an effect depends on the serine content of
the diet16.  It has been suggested that SDH is induced as a
response to the amount of surplus amino acids from dietary
protein taken beyond the body’s requirement17,18.  According
to the Institute of Life Science of the Ajinomoto Co., Inc.,
the supplier of the test compound, a lower blood threonine
level was observed in rats administered L-Ser in diet for 14
days (Kawamata Y. et al., data not shown), and this lowered
threonine level was considered to be related to induction of
SDH (Sakai R., personal communication).  If the lowered
serum TP and ALB levels in the rats administered L-Ser
(20% casein diet) in the present study were indeed treatment-
related, these changes might be due to the decrease of
threonine by induction of SDH as a sort of adaptive
response.
In the literature, D-Ser is reported to be toxic and to
cause kidney necrosis6,8.  D-Ser administration has been
shown to result in marked increases of urinary protein and
amino acid content and glucose excretion, possibly by virtue
of a direct effect on kidney function19,20.  This D-Ser-induced
aminoaciduria is attributed to impaired reabsorption of
amino acids by injured proximal straight tubules, as well as
to backward diffusion of amino acids from the interstitium20.
Maekawa et al. determined that D-amino acid oxidase is
involved in D-Ser-induced nephrotoxicity because
intraperitoneally administered D-Ser causes glucosuria and
polyuria in Fischer 344 rats but not in LEA/SENDAI rats
lacking D-amino acid oxidase21.  Regarding these renal
toxicities of serine, Ganote et al. described that
intraperitoneal administration of D-Ser to rats at a dose of 75
or 80 mg/100 g body weight causes reversible but selective
diffuse necrosis of the proximal straight tubules but that
similarly administered L-Ser does not exert this kind of
effect22.  In the present study, L-Ser produced no treatment-
related functional or morphological renal injury in rats.  It is
thus likely that the renal toxicity of serine depends on its
optical isomerism, namely, D-isomer-specific.
It is known that all of the assessed analogs and
derivatives of L-Ser have sedative effects, although the
amino acid acts in a different manner towards several
behavioral stress markers for such things as spontaneous
activity and distress vocalizations23.  Asechi et al. has
confirmed that L-Ser may be effective in improving anxiety
or sleep disorders induced by psychological stressors.  L-Ser
administered intracerebroventricularly has sedative and
Table 6. Histopathology in Fischer 344 Rats Given L-Ser for 90 Days
Item Dietary dose of L-Ser (%)
0 (control) 0.06 0.15 1.5 5.0
Male
Effective number of rats 10 10 10 10 10
Liver
Necrosis of hepatocytes 2a 01 0 2
Microgranulation 0 1 2 0 1
Inflammatory cell infiltration 10 9 9 8 10
Kidney
Regeneration of renal tubules 10 10 9 10 10
Inflammatory cell infiltration 0 0 1 0 1
Mineralization 3 2 4 4 4
Female
Effective number of rats 10 10 10 10 10
Liver
Necrosis of hepatocytes 2 2 0 0 1
Microgranulation 0 0 0 0 1
Inflammatory cell infiltration 10 10 10 9 8
Kidney
Regeneration of renal tubules 5 3 1 1 2
Inflammatory cell infiltration 0 0 1 1 0
Mineralization 10 9 10 6 9
a Number of rats with lesions.46 A 90-day Feeding Toxicity Study of L-Ser
hypnotic effects on neonatal chicks under acute stressful
conditions24.  In the present study using young adult rats, no
signs or symptoms suggesting neurotoxicity of L-Ser were
observed.
Kaneko et al. recently reported the results of a
subchronic toxicity study of L-Ser in Sprague-Dawley rats
by gavage25.  They noted no treatment-related,
toxicologically significant changes in body weights, food
consumption, outcomes of urinalysis, hematology or serum
biochemistry, organ weights, or macroscopic or
histopathological examinations in any treatment groups, and
the no-observed-effect level (NOEL) was 3000 mg/kg body
weight/day for both sexes25.  In our present study using a
purified 20% casein diet in Fischer 344 rats, several
significant changes were observed between some of the
treated groups and the controls in hematology, serum
biochemistry and organ weights.  However, these changes
were subtle and lacked dose-dependence, and no
abnormalities were observed that corresponded to
pathological findings.  Although there were consistent and
inconsistent changes in several of the assessed parameters,
the outcomes of both studies were thus fundamentally
identical.  Based on these 2 studies, therefore, it is safe to
infer that L-Ser is not harmful in rats up to considerably high
dose levels when exposed orally.
In conclusion, the no-observed-adverse-effect-level
(NOAEL) for L-Ser was determined to be at least a dietary
dose of 5.0% (2765.0 mg/kg body weight/day for males and
2905.1 mg/kg body weight/day for females) under the
present experimental conditions.
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